本頁面由Tiger Trade Technology Pte. Ltd.提供服務

10x Genomics, Inc.

64.72
+0.92001.44%
盤後64.66-0.0600-0.09%16:12 EDT
成交量:412.67萬
成交額:2.69億
市值:84.32億
市盈率:-110.00
高:66.94
開:64.20
低:62.51
收:63.80
52周最高:66.94
52周最低:11.16
股本:1.30億
流通股本:1.18億
量比:1.28
換手率:3.50%
股息:- -
股息率:- -
每股收益(TTM):-0.5884
每股收益(LYR):-0.3490
淨資產收益率:-9.40%
總資產收益率:-5.05%
市淨率:10.21
市盈率(LYR):-185.42

資料載入中...

2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

重要事件披露

Form 8-K - Current report
2025/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/07

重要事件披露

Form 8-K - Current report
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/08

重要事件披露

Form 8-K - Current report